Scancell (LON:SCLP) Trading 29.8% Higher – Here’s Why

Scancell Holdings plc (LON:SCLP) traded up 29.8% during trading on Monday . The stock traded as high as GBX 11.38 ($0.15) and last traded at GBX 11 ($0.14). 10,537,342 shares were traded during mid-day trading, an increase of 1,073% from the average session volume of 897,982 shares. The stock had previously closed at GBX 8.48 ($0.11).

Scancell Trading Up 29.8 %

The stock has a 50-day moving average price of GBX 8.43 and a two-hundred day moving average price of GBX 10.88. The stock has a market capitalization of £113.93 million, a PE ratio of -16.86 and a beta of 0.35. The company has a debt-to-equity ratio of -566.79, a quick ratio of 13.01 and a current ratio of 3.42.

Scancell (LON:SCLP) last released its earnings results on Thursday, January 30th. The company reported GBX (1.35) (($0.02)) earnings per share for the quarter. As a group, equities analysts forecast that Scancell Holdings plc will post -2.5361112 earnings per share for the current year.

About Scancell

Scancell (LSE:SCLP) is a clinical stage immunotherapy biotech company developing treatments for significant unmet needs in cancer. We aim to translate our innovation and creativity into increased and durable responses in patients without compromising safety, addressing hard-to-treat cancers.

Scancell has developed a pipeline of ‘off-the-shelf’ vaccines to induce immune responses and highly tumour specific monoclonal antibodies to redirect immune cells or drugs.